IMM says TACTI-004 discontinuation impaired results
IMM reports impairment linked to discontinued TACTI-004, citing strong cash and positive clinical data supporting future prospects.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.